EA-5355

EA-5355
Clinical data
ATC code	none;
Identifiers
	IUPAC name 8-[4-(p-Fluorophenyl)-4,4-ethylenedioxy-1-butyl)-1-methyl-1,4,8-triazaspiro[4.5]decan-3-one;
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C20H28FN3O3
Molar mass	377.460 g·mol−1
	InChI InChI=1/C20H28FN3O3/c1-23-15-18(25)22-19(23)8-11-24(12-9-19)10-2-7-20(26-13-14-27-20)16-3-5-17(21)6-4-16/h3-6H,2,7-15H2,1H3,(H,22,25);

Script error: No such module "AfC submission catcheck".

EA-5355 is a spirocyclic derivative related to butyrophenone. It is based on the series of compounds originating from the laboratories of P. A. J. Janssen. EA-5355 is a skeleton-modified butyrophenone, conferring enhanced biological activity.^[1]

References[edit]

This article "EA-5355" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:EA-5355. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.

↑ EDGEWOOD ARSENAL TECHNICAL REPORT. EATR 4612. SYNTHESIS OF SPIROCYCLIC DERIVATIVES RELATED TO THE BUTYROPHENONE NEUROLEPTICS. by Leon J. Schiff and Patrick J. Mudd

[1] EDGEWOOD ARSENAL TECHNICAL REPORT. EATR 4612. SYNTHESIS OF SPIROCYCLIC DERIVATIVES RELATED TO THE BUTYROPHENONE NEUROLEPTICS. by Leon J. Schiff and Patrick J. Mudd

[1]

Clinical data

ATC code	none
Identifiers
IUPAC name 8-[4-(p-Fluorophenyl)-4,4-ethylenedioxy-1-butyl)-1-methyl-1,4,8-triazaspiro[4.5]decan-3-one
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C₂₀H₂₈FN₃O₃
Molar mass	377.460 g·mol⁻¹
InChI InChI=1/C20H28FN3O3/c1-23-15-18(25)22-19(23)8-11-24(12-9-19)10-2-7-20(26-13-14-27-20)16-3-5-17(21)6-4-16/h3-6H,2,7-15H2,1H3,(H,22,25)

EA-5355

References[edit]

📰 Article(s) of the same category(ies)[edit]